Cargando…
COVID-19 Vaccination and Glomerulonephritis
INTRODUCTION: mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited. We report a case series of patients who developed new or relapsin...
Autores principales: | Klomjit, Nattawat, Alexander, Mariam Priya, Fervenza, Fernando C., Zoghby, Ziad, Garg, Arvind, Hogan, Marie C., Nasr, Samih H., Minshar, Marwan Abu, Zand, Ladan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493782/ https://www.ncbi.nlm.nih.gov/pubmed/34632166 http://dx.doi.org/10.1016/j.ekir.2021.09.008 |
Ejemplares similares
-
COVID-19 and Glomerular Diseases
por: Klomjit, Nattawat, et al.
Publicado: (2023) -
Atypical post-infectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement
por: Sethi, Sanjeev, et al.
Publicado: (2012) -
C3 Glomerulonephritis: Clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up
por: Sethi, Sanjeev, et al.
Publicado: (2012) -
Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016) -
Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations
por: Sethi, Sanjeev, et al.
Publicado: (2014)